AAHRPP Changes Process, Awards Fewer Accreditations

Monday, December 28, 2009 08:30 AM

Organizations accredited by the Accreditation of Human Research Protection Programs (AAHRPP) will soon be able to go longer between accreditation renewals as part of a number of process changes effective January 1.  

AAHRPP extended the time period between reaccreditations from three years to five while the period between initial accreditation and reaccreditation remains at three years.  The organization also revised its reporting procedure to request more specific information about changes and catastrophic events.  In addition, AAHRPP’s Council on Accreditation may now request status reports and conduct limited site visits to organizations to verify standards-compliance efforts.

AAHRPP accredits organizations that conduct or review research with humans. The non-profit accredited six organizations at the end of 2009, bringing the total number of AAHRPP clients to 200. Forty-one organizations were accredited in 2009, down from 67 in 2008.

The list of organizations that received full accreditation in December includes: Spectrum Health, Grand Rapids, Mich.; South Shore Hospital, South Weymouth, Mass.; HealthPartners Research Foundation, Minneapolis, Minn., The University of North Carolina at Chapel Hill, Chapel Hill, N.C., Independent Investigational Review Board, Plantation, Fla.; and Liberty IRB, DeLand, Fla.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs